Impact of intensive care unit admission on the resumption of treatment in patients with cancer: a systematic review and meta-analysis.
Support Care CancerAug 31, 2026 (epub)
Raisa do Val Roso, Renato Daltro-Oliveira, Laveena Munshi et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated the resumption of anticancer treatment in adult patients with cancer after unplanned ICU admission. Analyzing 20 studies with 3,551 patients, the findings revealed that 61% of patients resumed any anticancer treatment post-discharge, while only 48% continued their originally planned regimen at 6 months.
Key findings
- 61% of patients resumed any anticancer treatment after ICU discharge.
- Resumption rates were 60% for solid tumors and 77% for hematological malignancies.
- Only 48% of patients continued their originally planned treatment at 6 months.
Why it matters
Understanding treatment resumption rates after ICU admission is crucial for oncologists to manage patient care effectively. It highlights the need for timely reassessment of treatment plans and patient preferences following critical illness.